VCYT
Veracyte, Inc.
Stock
$45.81+1.62 (+3.67%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $178M | $136M | $75M | $44M | $7.5M | −$32M | −$9.7M | −$3.2M | −$14M | −$24M | −$28M | −$27M | −$28M | −$19M | −$7.2M | −$14M |
| Capital expenditures | $12M | $9.7M | $11M | $10.0M | $8.5M | $5.4M | $2.8M | $2.8M | $1.9M | $1.8M | $4.2M | $6.2M | $2.0M | $1.3M | $1.5M | $276K |
| Free cash flow | $166M | $127M | $64M | $34M | −$1.0M | −$37M | −$13M | −$6.0M | −$15M | −$26M | −$32M | −$33M | −$30M | −$20M | −$8.6M | −$14M |
| Stock-based compensation | $49M | $44M | $36M | $33M | $27M | $23M | $13M | $9.8M | $6.0M | $6.6M | $6.4M | $5.6M | $3.5M | $1.2M | — | — |
| Free cash flow margin | 29.5% | 24.5% | 14.3% | 9.5% | −0.3% | −16.9% | −10.7% | −5.0% | −16.7% | −35.7% | −49.5% | −66.9% | −77.7% | −93.6% | −74.2% | −521.7% |